PUBLISHER: Grand View Research | PRODUCT CODE: 1474865
PUBLISHER: Grand View Research | PRODUCT CODE: 1474865
The global veterinary artificial insemination market is anticipated to reach USD 11.25 billion by 2030 and is projected to grow at a CAGR of 6.34% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the market growth include increasing consumption of animal protein, growing demand for livestock productivity, and adoption of sexed semen. In March 2023, Genetics Australia - the country's largest artificial breeding supplier announced that it would merge with URUS - a leading player in the veterinary artificial insemination industry. This would provide Genetics Australia access to global markets in marketing Australian genetics.
The COVID-19 pandemic resulted in many challenges including dampened growth, decreased sales and marketing activities, supply chain hurdles, and delays in the delivery of AI services. The erratic and uncertain consumption patterns in several key markets exacerbated by sporadic lockdowns and logistical bottlenecks further increased the uncertainty in the market. The growth was also dampened by other factors such as the African Swine-Fever. Genus, for instance, reported labor shortages, adverse impact on retail food service demand and meat packing capacity, and international logistics delays due to the pandemic. The company indicated that in the near-term, feed input costs, ASF, and COVID-19 implications would continue to exert pressure on the global porcine industry, particularly in China and Europe. In North America, the pandemic led to packing plant slowdowns during H1 of 2021.
To fulfill the continuously increasing demand for meat and dairy products, market players are expanding artificial insemination solutions to breed high-quality livestock and enhance production. For example, in August 2020, Cogent with AB Europe launched a novel sexed semen service for U.K. sheep producers. In September 2021, LIC- an agritech co-operative based in New Zealand launched a sexed semen lab in the country to meet the growing demand. This boosted the cooperative's capabilities to artificially inseminate about 4.5 million cattle between the Spring mating season of September to December 2021. Developing regions such as Latin America are also contributing to the market growth for veterinary artificial insemination. For instance, Brazil, one of the major countries in the region has been adopting AI increasingly for the past decade. The country has also deployed Fixed-Time Artificial Insemination (FTAI) techniques to increase profitability and success rate.